Drug intelligence / Profile preview

AK-1402

Development stage
Preclinical
Lead developer
University of Mississippi
Modality
Small Molecules
Administration
Oral
01

Overview

AK-1402 (2-O-salvinorin B benzo[b]thiophene-2-carboxylate) is a synthetic C(2)-fused-heteroaromatic ester analogue of salvinorin A, a neoclerodane diterpene naturally found in *Salvia divinorum*. Developed by researchers at the University of Mississippi and the Universidade Federal de Goiás, AK-1402 is being investigated for its potential antinociceptive, anxiolytic-like, and antidepressant-like properties. Unlike salvinorin A, which is a highly selective kappa-opioid receptor (KOR) agonist with strong hallucinogenic and anxiogenic side effects, AK-1402 is designed to elicit therapeutic effects with improved pharmacological profiles. Preclinical studies in mice suggest that its antinociceptive and anxiolytic-like activities involve the modulation of opioid receptors (specifically KOR and potentially mu-opioid receptors) and the benzodiazepine binding site of GABA-A receptors, while its antidepressant-like effects are mediated through monoaminergic pathways.

Other names
2-O-salvinorin B benzo[b]thiophene-2-carboxylate
02

Targets

GABRR (GABA-A receptor subunit rho)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on AK-1402.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AK-1402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call